Eli Lilly and Innovent Biologics have expanded their collaboration deal and defined the distribution rights for up to three co-developed, experimental cancer drugs.
WSJ.com About China, Wall Street Journal: World: China
Mon, 10/12/2015 - 3:52am
Eli Lilly and Innovent Biologics have expanded their collaboration deal and defined the distribution rights for up to three co-developed, experimental cancer drugs.